Hanmi Science Co., Ltd. (KRX:008930)
South Korea · Delayed Price · Currency is KRW 44,700
+2,100 (4.93%)
At close: Feb 4, 2026
Hanmi Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,344,641 | 1,283,432 | 1,247,906 | 1,046,054 | 950,165 | 857,383 |
Other Revenue | -1,731 | - | - | - | - | - |
| 1,342,910 | 1,283,432 | 1,247,906 | 1,046,054 | 950,165 | 857,383 | |
Revenue Growth (YoY) | -0.06% | 2.85% | 19.30% | 10.09% | 10.82% | 4.99% |
Cost of Revenue | 1,043,925 | 1,015,152 | 986,452 | 886,360 | 1,673 | 738,393 |
Gross Profit | 298,985 | 268,280 | 261,455 | 159,694 | 948,491 | 118,990 |
Selling, General & Admin | 236,929 | 220,611 | 195,711 | 126,104 | 914,482 | 86,674 |
Other Operating Expenses | - | - | - | - | - | 920.41 |
Operating Expenses | 246,273 | 230,322 | 204,443 | 131,583 | 919,739 | 93,838 |
Operating Income | 52,712 | 37,958 | 57,012 | 28,112 | 28,753 | 25,152 |
Interest Expense | -10,687 | -11,346 | -10,161 | -3,689 | -1,794 | -1,696 |
Interest & Investment Income | 2,163 | 1,524 | 643.37 | 164.12 | 94.61 | 130.51 |
Earnings From Equity Investments | 60,910 | 60,910 | 84,501 | 39,514 | 24,234 | 7,350 |
Currency Exchange Gain (Loss) | 2,509 | 853.74 | -19.9 | 425.09 | -285.85 | 28.87 |
Other Non Operating Income (Expenses) | -14,814 | -16,694 | -735.98 | 8,901 | -1,791 | -840.9 |
EBT Excluding Unusual Items | 92,794 | 73,207 | 131,240 | 73,426 | 49,211 | 30,125 |
Gain (Loss) on Sale of Investments | 153.02 | 402.35 | -3.33 | -2.71 | -41.85 | -158.2 |
Gain (Loss) on Sale of Assets | 13.64 | 10.9 | -37.88 | 23.48 | 1.33 | -0.19 |
Asset Writedown | -10,530 | -10,525 | -656.65 | -267.48 | -48.21 | - |
Pretax Income | 82,431 | 63,095 | 130,542 | 73,180 | 49,122 | 29,966 |
Income Tax Expense | 9,781 | 6,402 | 15,422 | 4,144 | 6,182 | 7,370 |
Earnings From Continuing Operations | 72,650 | 56,693 | 115,120 | 69,035 | 42,940 | 22,597 |
Minority Interest in Earnings | 2,492 | 2,729 | 1.65 | 174.26 | 2.07 | 4.49 |
Net Income | 75,142 | 59,422 | 115,122 | 69,210 | 42,942 | 22,601 |
Net Income to Common | 75,142 | 59,422 | 115,122 | 69,210 | 42,942 | 22,601 |
Net Income Growth | -28.41% | -48.38% | 66.34% | 61.17% | 90.00% | -26.48% |
Shares Outstanding (Basic) | 68 | 68 | 68 | 68 | 69 | 69 |
Shares Outstanding (Diluted) | 68 | 68 | 68 | 68 | 69 | 69 |
Shares Change (YoY) | -0.13% | -0.35% | -0.79% | -0.18% | -0.02% | -0.01% |
EPS (Basic) | 1110.10 | 877.52 | 1694.06 | 1010.45 | 625.80 | 329.31 |
EPS (Diluted) | 1110.10 | 877.52 | 1694.06 | 1010.45 | 625.80 | 329.31 |
EPS Growth | -28.32% | -48.20% | 67.66% | 61.47% | 90.04% | -26.47% |
Free Cash Flow | 56,681 | 73,154 | 28,228 | 2,054 | 11,874 | 12,859 |
Free Cash Flow Per Share | 837.37 | 1080.31 | 415.38 | 29.99 | 173.04 | 187.36 |
Dividend Per Share | 300.000 | 300.000 | - | - | - | - |
Gross Margin | 22.26% | 20.90% | 20.95% | 15.27% | 99.82% | 13.88% |
Operating Margin | 3.92% | 2.96% | 4.57% | 2.69% | 3.03% | 2.93% |
Profit Margin | 5.59% | 4.63% | 9.22% | 6.62% | 4.52% | 2.64% |
Free Cash Flow Margin | 4.22% | 5.70% | 2.26% | 0.20% | 1.25% | 1.50% |
EBITDA | 62,055 | 47,669 | 65,744 | 33,590 | 34,009 | 31,360 |
EBITDA Margin | 4.62% | 3.71% | 5.27% | 3.21% | 3.58% | 3.66% |
D&A For EBITDA | 9,343 | 9,711 | 8,732 | 5,478 | 5,257 | 6,208 |
EBIT | 52,712 | 37,958 | 57,012 | 28,112 | 28,753 | 25,152 |
EBIT Margin | 3.92% | 2.96% | 4.57% | 2.69% | 3.03% | 2.93% |
Effective Tax Rate | 11.87% | 10.15% | 11.81% | 5.66% | 12.58% | 24.59% |
Advertising Expenses | - | 15,017 | 12,222 | 7,083 | 5,389 | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.